Beyond one-size-fits-all: single-cell transcriptomic signatures predict drug efficacy and reveal responder subgroups in endometriosis
Raúl Pérez-Moraga, Cemsel Bafligil, Sarah Louise Harden…·Cristina Fernández Molina
This paper uses single-cell transcriptomics to identify drug response subgroups and therapeutic targets in endometriosis, revealing tissue-specific and inter-patient heterogeneity.